Product
QTX3046
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase 1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of QTX3046 in Patients With Advanced Solid Tumors With KRAS G12D MutationsStatus: Not yet recruiting, Estimated PCD: 2027-07-01